Executive record
Kevin G. Sarney
Kevin G. Sarney holds the CFO seat at Atara Biotherapeutics, Inc. on the record, interim chief financial officer, effective June 26, 2026.
1 verified record · 1 company · current seat on the record: Atara Biotherapeutics, Inc.
Career line from the records
1Each seat as a filing states it, newest first. Titles appear only as the filing prints them for this person.
2026-06-26InterimAtara Biotherapeutics, Inc.current seat
Atara Biotherapeutics, Inc. names Kevin G. Sarney interim CFONamed as the incoming officer, interim chief financial officer
effective June 26, 2026 · 8-K filed June 26, 2026 · sec.gov, Item 5.02
Companies
1This page lists only verified filing records that name Kevin G. Sarney, matched by the name as the filings print it; it is not a career history. Corrections: the corrections page.